Q: I am thinking of adding some mutual funds to my portfolio. Specifically I am looking at the Mawer funds with fairly low Mer and with no trailer fees. Maw 104, 106, 108, 120. These all have fairly good track records. Appreciate your thoughts.
Q: Brookfield infrastructure LP (BIP.UN) and Brookfield Residential properties (BRP) both seemed to have posted very good results but have had a very muted response. What is your take on these two stocks?
thankyou.
Q: Hi Peter and team. Can't thank you enough for your advice and analysis. I haven't had so much fun in the market in years. Yeah PLB!!! What are your thoughts on Dundee Reit. (D.UN) I am underwater on this and am wondering if it is dead money whether I should bail. Thanks Cathy
Q: Hi Team
It looks like investors are giving up on Pen West as it has taken a big hit this week> i was going to hang in there and give the new management a chance but am considering switching my investment to surge energy. Do you see this as a wise move
Q: Your comments on HLP.Un after their recent earnings report Please. Also any comments you may have on AET.UN on it's erratic behavior notwithstanding generally good news and favourable company comments about the distribution into 2014. Thanks
Q: I am not certain that you received my email: I noticed that at least two other members' questions had gone astray last week, and am wondering if the same happened here.
My request was, roughly, as follows:
1. Would you be able to provide a preferred comparison of AIG and MET: wondering if either one of these is a good play for insurance exposure, or would you recommend a Canadian
life-co over either one of those?
2. XEG: I have been simply "breaking even" on this one for the better part of 18 months and would like to switch to something with at least "some" growth in the energy sector. I was thinking of walking away from the ETF and switching to CNQ perhaps. What would be your opinion?
Q: Bristol Myers(BMY)has had a very good run in the past 12 months, but revenue growth and earnings growth are going in the wrong direction. The company seems expensive at current levels. Is drug pipeline hope causing the premium and is it warranted or is the company just over-priced?
You like EFN for certain reasons but it is stuck in a range for quite some time now. Their current PE ratio is way high compared to the others. They are reporting on the 13th. Do you think they can significantly improve upon their earnings this time. How would you rank EFN from among the following list: HCG, SUM, RFC, EH, CFN, EFN and CXS.